Large-scale testing (Phase 3)Ended earlyNCT00171431
What this trial is testing
The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)
Who this might be right for
Constipation PredominantIrritable Bowel Syndrome (IBS-C)
Novartis Pharmaceuticals 20